Global University Venturing

MIT Media Lab's E14 fund has contributed to a round that will fund research and development for the logistics management platform developer.

Rutgers University-New Brunswick has spun out Infinity Biologix with backing from Viking Global Investors to manage the distribution of a saliva-based coronavirus test.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

TU Delft and Imperial-founded genetic data analytics software provider BlueBee has been picked up after raising at least $13.5m of funding.

Vanderbilt University was among the participants in a $75.9m round for Monzo that cut the mobile bank's valuation from more than $2.5bn to under $1.6bn.

Grand Decade and existing investor Boehringer Ingelheim Venture Fund helped supply $38.2m for the mRNA immunotherapy developer and Vrije Universiteit Brussel spinout.

Uniseed has entered a co-investment pact with BioCurate, a drug discovery fund for early-stage University of Melbourne and Monash University research.

Founded by University of Washington faculty, Proprio has raised series A funding to commercialise its multi-camera surgical imaging system.

Chalmers Ventures portfolio company Biofrigas has set out plans for a $1.7m IPO but has already issued around $1.2m to existing connections.

The demographic phenomenon of ageing populations will present challenges to both developed and developing nations. Along with the challenges come opportunities, however, and corporate venture capitalists may be a particularly well-positioned group to help with them, as it is the connecting tissue between the world of incumbent corporate industry leaders and the space of disruptive innovation.

The carmaker has followed up a $100m investment two years ago with a pledge to provide up to $200m for the Stanford-originated solid-state battery developer.